Stock FLRY3 FLEURY S.A.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Fleury S.A.

Equities

FLRY3

BRFLRYACNOR5

Healthcare Facilities & Services

Market Closed - Sao Paulo
Other stock markets
 04:07:40 2024-07-10 pm EDT 		5-day change 1st Jan Change
15.43 BRL +10.14% Intraday chart for Fleury S.A. +2.66% -14.47%
May. 10 Fleury Seeks Acquisitions CI
May. 10 Transcript : Fleury S.A., Q1 2024 Earnings Call, May 10, 2024

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 9,670 8,575 5,702 5,661 9,864 8,440 - -
Enterprise Value (EV) 1 10,452 9,476 7,854 5,661 13,181 11,850 11,883 11,871
P/E ratio 31.2 x 33.8 x 16.4 x 16.3 x 20.7 x 12.9 x 11 x 9.87 x
Yield 2.03% 2.7% 5.97% - - 4.84% 6.28% 7.18%
Capitalization / Revenue 3.33 x 2.89 x 1.47 x 1.27 x 1.52 x 1.08 x 1.01 x 0.96 x
EV / Revenue 3.6 x 3.19 x 2.03 x 1.27 x 2.04 x 1.52 x 1.42 x 1.35 x
EV / EBITDA 14.2 x 11.3 x 7.44 x 4.76 x 7.55 x 5.88 x 5.42 x 5.14 x
EV / FCF 29.1 x 20.6 x 13 x - 12.9 x 14.2 x 13.4 x 12.5 x
FCF Yield 3.44% 4.85% 7.71% - 7.78% 7.04% 7.46% 7.98%
Price to Book 5.5 x 4.9 x 3.09 x - 1.72 x 1.59 x 1.53 x 1.57 x
Nbr of stocks (in thousands) 332,582 333,235 332,818 384,725 546,806 545,590 - -
Reference price 2 29.08 25.73 17.13 14.71 18.04 15.43 15.43 15.43
Announcement Date 2/20/20 2/25/21 3/17/22 3/16/23 3/7/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,905 2,972 3,873 4,463 6,471 7,790 8,367 8,803
EBITDA 1 737.7 837.5 1,056 1,190 1,746 2,016 2,191 2,310
EBIT 1 560.2 478.7 667.3 735 915.9 1,264 1,426 1,551
Operating Margin 19.28% 16.11% 17.23% 16.47% 14.15% 16.23% 17.04% 17.62%
Earnings before Tax (EBT) 1 426.2 340.7 496.1 405.4 531.3 866.3 1,041 1,138
Net income 1 312.3 257 349.9 307.9 423.8 655 769.3 856.2
Net margin 10.75% 8.65% 9.04% 6.9% 6.55% 8.41% 9.19% 9.73%
EPS 2 0.9333 0.7619 1.048 0.9048 0.8700 1.198 1.407 1.564
Free Cash Flow 1 359.2 459.3 605.4 - 1,025 834.4 886.2 947.5
FCF margin 12.36% 15.46% 15.63% - 15.85% 10.71% 10.59% 10.76%
FCF Conversion (EBITDA) 48.69% 54.85% 57.33% - 58.75% 41.39% 40.44% 41.02%
FCF Conversion (Net income) 115.01% 178.75% 173.02% - 242% 127.4% 115.19% 110.67%
Dividend per Share 2 0.5905 0.6943 1.023 - - 0.7462 0.9685 1.107
Announcement Date 2/20/20 2/25/21 3/17/22 3/16/23 3/7/24 - - -
1BRL in Million2BRL
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 1,018 1,090 1,112 1,147 1,115 1,237 1,660 1,870 1,704 1,904 1,978 1,998 1,838 2,049 -
EBITDA 1 262.2 326.6 298 332.4 232.7 345.8 363.6 506 530.2 517.1 524.3 545.2 409.9 - -
EBIT 1 154.8 219.1 184.6 222.9 108.3 214.5 197.8 318 185.7 327.2 334.5 357.1 235 368.6 -
Operating Margin 15.2% 20.1% 16.6% 19.44% 9.72% 17.34% 11.92% 17% 10.89% 17.18% 16.91% 17.87% 12.79% 17.99% -
Earnings before Tax (EBT) 1 99.4 153.5 98.23 123.5 30.12 - - - - 217 230.6 249.4 119.7 - -
Net income 70.8 110.4 70.51 96.01 30.95 93.85 74.43 174.2 81.28 168 - - - - -
Net margin 6.96% 10.13% 6.34% 8.37% 2.78% 7.59% 4.48% 9.32% 4.77% 8.82% - - - - -
EPS 2 0.2095 0.3333 0.2127 0.2857 0.0730 0.2476 0.2400 0.3100 0.1600 0.3100 0.3142 0.3449 0.1857 0.3400 0.3700
Dividend per Share 2 0.8952 - - - - - - - - - 0.2210 - 0.8670 - -
Announcement Date 3/17/22 5/5/22 8/4/22 11/3/22 3/16/23 5/4/23 8/3/23 11/9/23 3/7/24 5/9/24 - - - - -
1BRL in Million2BRL
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 781 901 2,152 - 3,317 3,410 3,443 3,431
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.059 x 1.076 x 2.037 x - 1.9 x 1.691 x 1.571 x 1.485 x
Free Cash Flow 1 359 459 605 - 1,025 834 886 948
ROE (net income / shareholders' equity) 19.8% 14.6% 19.5% - 10.9% 12.7% 13.6% 15.1%
ROA (Net income/ Total Assets) 7.71% 4.84% 6.04% - 4.38% 5.14% 5.83% 6.24%
Assets 1 4,052 5,310 5,794 - 9,686 12,735 13,200 13,723
Book Value Per Share 2 5.290 5.260 5.540 - 10.50 9.720 10.10 9.820
Cash Flow per Share 2.180 1.930 3.050 - 2.970 - - -
Capex 1 208 188 413 - 414 457 564 573
Capex / Sales 7.15% 6.32% 10.67% - 6.4% 5.87% 6.74% 6.5%
Announcement Date 2/20/20 2/25/21 3/17/22 3/16/23 3/7/24 - - -
1BRL in Million2BRL
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Fleury S.A.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
15.47 BRL
Average target price
18.83 BRL
Spread / Average Target
+21.74%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical & Diagnostic Laboratories

1st Jan change Capi.
FLEURY S.A. Stock Fleury S.A.
-14.47% 1.55B
SONIC HEALTHCARE LIMITED Stock Sonic Healthcare Limited
-19.95% 8.38B
DR. LAL PATHLABS LIMITED Stock Dr. Lal PathLabs Limited
+14.39% 2.91B
SYNLAB AG Stock SYNLAB AG
-2.98% 2.63B
NEOGENOMICS, INC. Stock NeoGenomics, Inc.
-16.44% 1.71B
GUANGZHOU KINGMED DIAGNOSTICS GROUP CO., LTD. Stock Guangzhou Kingmed Diagnostics Group Co., Ltd.
-56.03% 1.6B
METROPOLIS HEALTHCARE LIMITED Stock Metropolis Healthcare Limited
+22.37% 1.26B
VIJAYA DIAGNOSTIC CENTRE LIMITED Stock Vijaya Diagnostic Centre Limited
+19.55% 1B
DIAN DIAGNOSTICS GROUP CO.,LTD. Stock Dian Diagnostics Group Co.,Ltd.
-47.12% 999M
OPKO HEALTH, INC. Stock OPKO Health, Inc.
-12.58% 899M
Medical & Diagnostic Laboratories
  1. Stock Market
  2. Equities
  3. FLRY3 Stock
  4. Financials Fleury S.A.